Article
HSP70iQ435A to subdue autoimmunity and support anti-tumor responses.
Cell stress & chaperones - 1 Sept 2021
Jaishankar Dinesh, Cosgrove Cormac, Ramesh Prathyaya, Mahon James, Shivde Rohan, Dellacecca Emilia R, Yang Shiayin F, Mosenson Jeffrey, Guevara-Patiño José A, Le Poole I Caroline
Abstract excerpt
Developing immunosuppressive therapies for autoimmune diseases comes with a caveat that immunosuppression may promote the risk of developing other conditions or diseases. We have previously shown that biolistic delivery of an expression construct encoding inducible HSP70 (HSP70i) with one amino acid modification in the dendritic cell (DC) activating moiety 435-445 (HSP70iQ435A) to mouse skin resulted in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
